BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.

News Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Equities

688621

CNE100005139

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
53.18 ^CNY	-4.78%		-5.63%	-23.76%

Apr. 25	Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 26	Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 26	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.(XSSC:688621) added to S&P Global BMI Index	23-09-18	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. cancelled the acquisition of Beijing Langyan Life Technology Holdings Co., Ltd. from a group of shareholders.	23-09-03	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Sun-Novo Pharma Gets License to Produce Kaneka’s Transdermal Patches	23-05-16	MT
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Sun-Novo Pharma Unit Gets Drug Regulator's Certification for Desmopressin Injection	23-04-13	MT
Sun-Novo Pharma Unit to Set Up 10 Million Joint Venture With Midea Pharma	23-04-12	MT
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. announced that it expects to receive CNY 1 billion in funding	23-04-10	CI
Sun-Novo Pharma Logs 49.8% Jump in 2022 Profit	23-02-10	MT
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-09	CI
Sun-Novo Pharmaceutical Purchases Azilsartan Tablets’ Marketing Rights For $5 Million	22-11-23	MT
Beijing Sun-Novo Gets Regulatory Approval in China For Anti-Dermatitis Cream	22-11-22	MT
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. announced that it expects to receive CNY 1 billion in funding	22-11-06	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. agreed to acquire Beijing Langyan Life Technology Holdings Co., Ltd. from Li Qian, Ganzhou Langyi Investment Center (Limited Partnership), Liu Yujing and other shareholders.	22-10-24	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-09	CI
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.(SHSE:688621) added to Shanghai Stock Exchange Composite Index	22-06-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Equities

688621

CNE100005139

Summary

Filters